Periprocedural myocardial infarction in chronic total occlusion: The challenge of precise diagnosis and...

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomarkers

Background:

• Periprocedural myocardial infarction (PMI) is a common complication following percutaneous coronary intervention (PCI), particularly in complex cases like chronic total occlusion PCI (CTO-PCI).
• The incidence of PMI is influenced by various factors, including the definition of myocardial infarction (MI) used (biomarker and threshold), specific lesion characteristics, and the procedural course of PCI.
• Understanding and predicting PMI is crucial for improving patient outcomes after PCI.

Discussion:

• This study aimed to identify key predictors of PMI specifically within the context of CTO-PCI.
• The research highlights the significant association between the occurrence of PMI and elevated peak levels of creatine kinase-MB (CK-MB).
• These findings underscore the clinical relevance of monitoring cardiac biomarkers post-CTO-PCI.

Key Insights:

• Predictors of periprocedural myocardial infarction (PMI) during chronic total occlusion percutaneous coronary intervention (CTO-PCI) were identified.
• Both the occurrence of PMI and the peak level of creatine kinase-MB (CK-MB) were found to be significantly associated with adverse clinical outcomes.
• These insights are vital for risk stratification and management strategies in patients undergoing CTO-PCI.

Outlook:

• Further research should focus on refining MI definitions and thresholds for CTO-PCI to improve diagnostic accuracy.
• Developing targeted preventative strategies based on identified PMI predictors could mitigate risks associated with CTO-PCI.
• Long-term outcome studies are needed to fully elucidate the impact of PMI on cardiac prognosis after CTO-PCI.